Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Date of authorisation: 08/12/2017, Revision: 10, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 March 2025 to 13 March 2025

PSUSA/00010239/202408

Human medicines European public assessment report (EPAR): Ongentys, opicapone, Date of authorisation: 24/06/2016, Revision: 10, Status: Authorised

Leveraging the power of data for public and animal health

Network Data Steering Group workplan 2025-2028

EMA starts review of Ixchiq (live attenuated chikungunya vaccine)

Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Date of authorisation: 03/12/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Daurismo, glasdegib, Date of authorisation: 26/06/2020, Revision: 6, Status: Authorised